Use, Spending, and Prices of Adalimumab Following Biosimilar Competition
This cross-sectional study examines the use, spending, and prices of adalimumab biosimilars in the first year of market competition in the US.
Authors
- Aaron Seth Kesselheim (ORCID: https://orcid.org/0000-0002-8867-2666)
- Benjamin N. Rome (ORCID: https://orcid.org/0000-0001-5776-3293)
- Anushka Bhaskar (ORCID: https://orcid.org/0000-0002-6018-9058)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1001/jamahealthforum.2024.3964
- Citations
- 5
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 5.65